Did Hedge Funds Drop The Ball On Clovis Oncology Inc (CLVS) ?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors......(read more)
Posts Tagged ‘NASDAQ:CLVS’
Were Hedge Funds Right About Dumping Clovis Oncology Inc (CLVS)?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred......(read more)
Hedge Fund and Insider Trading News: Ray Dalio, Tom Steyer, Bodenholm Capital, Balyasny Asset Management, AQR Capital, Magellan Midstream Partners, L.P. (MMP), Tucows Inc (TCX), and More
Billionaire Ray Dalio Says This is How to be ‘Truly Successful’ (CNBC) Hedge fund billionaire Ray Dalio knows plenty about success: He founded Bridgewater......(read more)
Hedge Fund and Insider Trading News: Tom Steyer, David Shaw, Ray Dalio, Keshik Capital, Facebook Inc. (FB), Cullen/Frost Bankers, Inc. (CFR), and More
Tom Steyer Takes a Week off Campaign Trail to Report for Jury Duty (Fox News) Apparently running for president is not a valid excuse for getting out of......(read more)
Is Clovis Oncology Inc (CLVS) A Good Stock To Buy?
Billionaire hedge fund managers such as David Abrams, Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year......(read more)
Here’s What Hedge Funds Think About About Clovis Oncology Inc (CLVS)
“October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers......(read more)
Argentiere Capital’s Returns, AUM and Holdings
Deepak Gulati‘s Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago. The......(read more)
Should You Avoid Clovis Oncology Inc (CLVS)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers......(read more)
How Clovis Oncology Inc (CLVS) Stacks Up Against Its Market Cap Peers
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which......(read more)
Clovis Oncology Inc (CLVS) is Trending After TESARO Inc (TSRO) Results
Clovis Oncology Inc (NASDAQ:CLVS) is on many watch lists today after the FDA formally approved TESARO Inc (NASDAQ:TSRO)’s niraparib. Niraparib......(read more)
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression. AstraZeneca......(read more)
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)
It’s been a big week for PARP inhibitors. AstraZeneca PLC (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza......(read more)
Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from......(read more)
Does Clovis Oncology Inc (CLVS) Represent a Good Addition to Your Portfolio?
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by......(read more)
Westmoreland Coal Company (WLB), Corrections Corp Of America (CXW): Here’s Why Traders Are Piling Into These Stocks
Like Britain’s decision to leave the EU, the unexpected occurred after Donald Trump beat Hillary Clinton to win the White House. As the future 45th......(read more)
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns
Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion......(read more)
Here’s Why These Five Stocks Are in the Red Today: Clovis Oncology, Tyson Foods, Lloyds Banking Group, and More
Although the broader markets are only down moderately after today’s rather disappointing jobs report, shares of five companies Clovis Oncology......(read more)
Why Traders Are Talking About Chevron, Adobe, Petrobras, and More
After being range-bound for the last few weeks, crude promises to be a little bit more volatile in the near-term following today’s release of......(read more)
Here’s Why These Five Stocks Are Trading Higher Today
Investors are buzzing about WTI today after today’s EIA report showed a significant drop in oil inventories, which confirmed the bullish API report......(read more)
Kyle Bass Makes Huge Bet Against McDonald’s, Sells Off Clovis
Although Kyle Bass of Hayman Advisors is famous for his macro trading such as shorting Japanese bonds or the housing market, his fund also places equity......(read more)
Here’s Why Many Smart Money Investors Are Bullish on Clovis Oncology
Clovis Oncology Inc (NASDAQ:CLVS) is a biopharmaceutical company focused on developing and commercializing anti-cancer agents. In this article, we examine......(read more)
Our Take On The Clovis Oncology Inc (CLVS) Announcement
Clovis Oncology Inc (NASDAQ:CLVS) just reported that the FDA has accepted its new drug application (NDA) and the company is up close to 30% ahead of the......(read more)
A Closer Look at Five Stocks in Spotlight Following Financial Reports
The US stock market inched up higher on Tuesday and the S&P 500 and NASDAQ reached new intraday highs. Five stocks are in the spotlight following......(read more)
Here’s Why These Five Stocks Are On the Move on Wednesday
On the second to last day before the end of the quarter, all three indexes and crude futures are higher. Among the stocks showing more volatility than......(read more)
Redmile Group Sticking With Healthcare Picks After Rough Q1
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......(read more)
Here’s Why These 5 Stocks Are Grabbing Headlines Today
Although the CBOE Volatility Index is at 14 and crude prices are near their 2016 highs, volatility is of course alive and well among individual stocks......(read more)
Fitbit Inc (FIT) Among 5 Stocks That Are Trending Today
At a time when all three indexes are in the green, shares of Canadian Pacific Railway Limited (USA) (NYSE:CP), Norfolk Southern Corp. (NYSE:NSC), Synergy......(read more)
What is Causing These 5 Stocks to Move Sharply on Friday?
While the indexes have had a moderately volatile day so far, shares of Clovis Oncology Inc (NASDAQ:CLVS), China Hgs Real Estate Inc (NASDAQ:HGSH), Amira......(read more)
HealthCor Management LP Increases Stake In Clovis Oncology, Inc. (CLVS)
Arthur B Cohen and Joseph Healey‘s HealthCor Management has filed a 13G with the Securities and Exchange Commission, disclosing its position in......(read more)
Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards‘ Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management. According to our calculations......(read more)
Redmile Group’s Top Q4 Moves as Its Long Positions Show Gains of 20% in 2015
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector. Redmile has an equity......(read more)
The Smart Money is Hoarding Shares of These 10 Healthcare Stocks, Part 2
In the first part in our series, we covered five healthcare stocks that the hedge funds in our database have favored heavily for one reason or another......(read more)
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States......(read more)
Clovis Oncology Inc (CLVS): Are Hedge Funds Right About This Stock?
We can judge whether Clovis Oncology Inc (NASDAQ:CLVS) is a good investment right now by following the lead of some of the best investors in the world......(read more)
Hedge Fund Sentiment Has This to Say About These Moves on 3 Healthcare Stocks
It is easy to imagine that hedge funds would not reveal their equity positions if it were not for reporting requirements enforced by the Securities......(read more)
These Four Stocks Are Getting Creamed Today
While Wall Street rallied into green territory from the opening bell on Monday, Dillard’s Inc. (NYSE:DDS), Marriott International Inc. (NASDAQ......(read more)
Should You Follow Hedge Fund Sentiment Of Wednesday’s Top 3 Healthcare Gainers?
As we have covered the top losers among healthcare stocks earlier today, which included three biotech companies, it’s time to take a look at some......(read more)
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX): Partner Fund Management’s Winning Bets in Healthcare and Tech
Headquartered in San Francisco, Partner Fund Management was established in 2004 by Christopher Medlock James. Based on its latest 13F filing, the fund......(read more)
Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday’s intraday trading to eventually close at 18% in the green at $72.48. The rise came......(read more)
Sientra Inc (SIEN), TESARO Inc (TSRO) and Clovis Oncology Inc (CLVS): Orbimed’s Top New Picks
Samuel Islay‘s Orbimed Advisors has revealed its equity portfolio as of end of 2014, in a recent filing with the Securities and Exchange Commission......(read more)
Insider Watch: 5 Stocks Scott D. Sandell Likes
Scott Sandell, a large shareholder and director with over 30 affiliations is the insider to watch for retail investors. He is the general partner of New......(read more)
Hedge Funds Are Dumping Dendreon Corporation (DNDN)
What’s a smart Dendreon Corporation (NASDAQ:DNDN) investor to do? To the average investor, there are tons of methods shareholders can use to monitor......(read more)
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of......(read more)
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use......(read more)
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Companies to Watch Out For
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth......(read more)
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe......(read more)
Tesla Motors Inc (TSLA) & Other Surprises That Are Beating Netflix, Inc. (NFLX) in 2013
Netflix, Inc. (NASDAQ:NFLX) has been a poster boy for market success in 2013. The stock has gained 134% in value during the first six months of the year......(read more)
Clovis Oncology Inc (CLVS), Sarepta Therapeutics Inc (SRPT): Three Healthcare Stocks to Keep an Eye On
The healthcare industry is slowly becoming what the pre-crash technology industry was of the early 2000’s. The emergence of new technologies......(read more)
Clovis Oncology Inc (CLVS), Synta Pharmaceuticals Corp. (SNTA): Post-ASCO Movers – Are Any a Buy?
Late last year, Clovis Oncology Inc (NASDAQ:CLVS) saw its share price cut in half, to $11.50, after reporting that its Phase 3 drug CO-101 failed to show......(read more)
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS): All About ASCO – 2013 Highlights
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column. This week was extraordinary, however, as we had......(read more)
